Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2‐year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry-Reference-Cited by-同舟云学术

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2‐year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry

Published:2021-05-06 Issue:1 Volume:100 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Gabrielle Pierre‐Henry¹²^ORCID,Nguyen Vuong¹,Creuzot‐Garcher Catherine²^ORCID,Miguel Lucia³,Alforja Socorro³^ORCID,Sararols Laura⁴,Casaroli‐Marano Ricardo P.³⁵⁶,Zarranz‐Ventura Javier³⁶^ORCID,Gillies Mark¹,Arnold Jennifer⁷,Barthelmes Daniel¹⁸

Affiliation:

1. Discipline of Ophthalmology Save Sight Institute Sydney Medical School The University of Sydney Sydney NSW Australia

2. Department of Ophthalmology Dijon University Hospital Dijon France

3. Clinical Institute of Ophthalmology (ICOF) Hospital Clinic Barcelona Spain

4. Hospital General de Catalunya Barcelona Spain

5. University of Barcelona Barcelona Spain

6. August Pi i Sunyer Biomedical Research Institute (IDIBAPS) Barcelona Spain

7. Marsden Eye Specialists Sydney NSW Australia

8. Department of Ophthalmology University Hospital Zurich University of Zurich Zurich Switzerland

Publisher

Wiley

Subject